Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Small-Molecule Poly(ADP-ribose) Polymerase and PD-L1 Inhibitor Conjugates as Dual-Action Anticancer Agents.

Ofori S, Awuah SG.

ACS Omega. 2019 Jul 24;4(7):12584-12597. doi: 10.1021/acsomega.9b01106. eCollection 2019 Jul 31.

2.

Equivalence in Active Pharmaceutical Ingredient of Generic Antihypertensive Medicines Available in Nigeria (EQUIMEDS): A Case for Further Surveillance.

Redfern J, Kaur H, Adedoyin RA, Ofori S, Anchala R, Vamadevan AS, De Andrade L, Zelaya J, Balabanova D, Sani MU.

Glob Heart. 2019 Sep;14(3):327-333. doi: 10.1016/j.gheart.2019.07.006.

PMID:
31451241
3.

Human Leukocyte Antigen-Associated HIV-1 CRF02_AG gag and vif Polymorphisms in Ghana.

Adusei-Poku MA, Matsuoka S, Bonney EY, Abana CZ, Duker EO, Nii-Trebi NI, Ofori SB, Mizutani T, Ishizaka A, Shiino T, Kawana-Tachikawa A, Ishikawa K, Ampofo WK, Matano T.

Jpn J Infect Dis. 2019 Nov 21;72(6):374-380. doi: 10.7883/yoken.JJID.2019.201. Epub 2019 Jun 28.

5.

Screening for Depressive Symptoms among Patients Attending Specialist Medical Outpatient Clinics in a Tertiary Hospital in Southern Nigeria.

Ofori SN, Adiukwu FN.

Psychiatry J. 2018 Oct 18;2018:7603580. doi: 10.1155/2018/7603580. eCollection 2018.

6.

Household biomass fuel use, blood pressure and carotid intima media thickness; a cross sectional study of rural dwelling women in Southern Nigeria.

Ofori SN, Fobil JN, Odia OJ.

Environ Pollut. 2018 Nov;242(Pt A):390-397. doi: 10.1016/j.envpol.2018.06.102. Epub 2018 Jul 4.

PMID:
30005252
7.

Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease.

Ofori S, Dodiyi-Manuel S, Akpa MR.

J Clin Lipidol. 2017 Nov - Dec;11(6):1441-1447. doi: 10.1016/j.jacl.2017.09.004. Epub 2017 Oct 3.

PMID:
29050979
8.

Physicochemical equivalence of generic antihypertensive medicines (EQUIMEDS): protocol for a quality of medicines assessment.

Redfern J, Adedoyin RA, Ofori S, Anchala R, Ajay VS, De Andrade L, Zelaya J, Kaur H, Balabanova D, Sani MU.

BMJ Glob Health. 2016 Sep 28;1(2):e000086. doi: 10.1136/bmjgh-2016-000086. eCollection 2016.

9.

Integrated programmes for cardiovascular disease risk reduction: the need for new models of care.

Ofori SN.

Heart. 2017 Jun;103(11):805-806. doi: 10.1136/heartjnl-2016-311084. Epub 2017 Mar 3. No abstract available.

PMID:
28258244
10.

Prevalence of hepatitis B virus co-infection among HIV-seropositive persons attending antiretroviral clinics in the Eastern Region of Ghana.

Kye-Duodu G, Nortey P, Malm K, Nyarko KM, Sackey SO, Ofori S, Afari EA.

Pan Afr Med J. 2016 Oct 1;25(Suppl 1):7. doi: 10.11604/pamj.supp.2016.25.1.6172. eCollection 2016.

11.

Risk assessment in the prevention of cardiovascular disease in low-resource settings.

Ofori SN, Odia OJ.

Indian Heart J. 2016 May-Jun;68(3):391-8. doi: 10.1016/j.ihj.2015.07.004. Epub 2015 Aug 29. Review.

13.

Palm oil and the heart: A review.

Odia OJ, Ofori S, Maduka O.

World J Cardiol. 2015 Mar 26;7(3):144-9. doi: 10.4330/wjc.v7.i3.144. Review.

14.

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting.

Ofori SN, Unachukwu CN.

Diabetes Metab Syndr Obes. 2014 May 23;7:159-68. doi: 10.2147/DMSO.S62320. eCollection 2014. Review.

15.

Serum uric acid and target organ damage in essential hypertension.

Ofori SN, Odia OJ.

Vasc Health Risk Manag. 2014 May 2;10:253-61. doi: 10.2147/VHRM.S61363. eCollection 2014.

16.

HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana.

Nii-Trebi NI, Ibe S, Barnor JS, Ishikawa K, Brandful JA, Ofori SB, Yamaoka S, Ampofo WK, Sugiura W.

PLoS One. 2013 Aug 19;8(8):e71972. doi: 10.1371/journal.pone.0071972. eCollection 2013.

17.

Overexpression of specific cysteine peptidases confers pathogenicity to a nonpathogenic Entamoeba histolytica clone.

Matthiesen J, Bär AK, Bartels AK, Marien D, Ofori S, Biller L, Tannich E, Lotter H, Bruchhaus I.

mBio. 2013 Mar 26;4(2). pii: e00072-13. doi: 10.1128/mBio.00072-13.

18.

Evaluation of antiretroviral therapy (ART) provision in an early cohort of patients initiating ART in Ghana.

Ohene SA, Addo NA, Zigah F, Newman M, Lartey M, Romero MA, Ofori S, Sheriff T, Ndanu T.

Pan Afr Med J. 2013 Nov 26;16:117. doi: 10.11604/pamj.2013.16.117.3136. eCollection 2013.

19.

Toward a risk-based assessment of the adult cancer survivor: late effects of chemotherapy.

Ofori S, Heddon MA, Griffis M.

Hosp Pract (1995). 2009 Dec;37(1):113-20. doi: 10.3810/hp.2009.12.264.

PMID:
20877179
20.

Generation of HIV-1 primary isolates representative of plasma variants using the U87.CD4 cell line.

Heeregrave EJ, Ampofo WK, Tetteh JK, Ofori M, Ofori SB, Shah AS, Pollakis G, Paxton WA.

J Virol Methods. 2010 Nov;169(2):341-50. doi: 10.1016/j.jviromet.2010.08.001. Epub 2010 Aug 10.

PMID:
20705104
21.

Okadaic acid modulates exocytotic and transporter-dependent release of dopamine in bovine retina in vitro.

Bugnon O, Ofori S, Schorderet M.

Naunyn Schmiedebergs Arch Pharmacol. 1995 Jan;351(1):53-9.

PMID:
7715742
22.

Effects of YM 435 and A 77636 on dopamine D-1 receptors in bovine retina in vitro.

Ofori S, De Raad S, Bugnon O, Schorderet M.

Gen Pharmacol. 1995 Jan;26(1):51-7.

PMID:
7713366
23.

Agonist-induced desensitization of dopamine D-1 receptors in bovine retina and rat striatum.

Ofori S, Bugnon O, Schorderet M.

J Pharmacol Exp Ther. 1993 Jul;266(1):350-7.

PMID:
8392558
24.

Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.

Heikkila RE, Hwang J, Ofori S, Geller HM, Nicklas WJ.

J Neurochem. 1990 Mar;54(3):743-50.

PMID:
2303810
25.

Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.

Danias P, Nicklas WJ, Ofori S, Shen J, Mytilineou C.

J Neurochem. 1989 Oct;53(4):1149-55.

PMID:
2788714
27.

Supplemental Content

Support Center